Kissei Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Kissei Pharmaceutical Co., Ltd. is publicly traded on JPX under the ticker 4547.T.
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products primarily in Japan. It offers Urief and Urief OD tablets for the treatment of dysuria; Glufast, Glubes, and Marizev tablets for type 2 diabetes; Darbepoetin Alfa BS and Epoetin Alfa BS injections for the treatment of renal anemia; Beova tablets for overactive bladder treatment; P-TOL chewable...
Can you invest in Kissei Pharmaceutical Co., Ltd.?
Yes. Kissei Pharmaceutical Co., Ltd. is publicly traded on JPX under the ticker 4547.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kissei Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.